The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

John A. Ford; Andrew Elders; Deepson Shyangdan; Pamela Royle; Norman Waugh

doi:10.1136/bmj.e5182

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

John A. Ford, Andrew Elders, Deepson Shyangdan, Pamela Royle, Norman Waugh

Research output: Contribution to journal › Article › peer-review

59 Citations (Scopus)

Abstract

To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

Original language	English
Article number	e5182
Journal	BMJ-British Medical Journal
Volume	345
DOIs	https://doi.org/10.1136/bmj.e5182
Publication status	Published - 2012

Keywords

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bayes Theorem
Diabetic Retinopathy
Humans
Macular Edema
Markov Chains
Monte Carlo Method
Treatment Outcome
Visual Acuity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmj.e5182

Cite this

@article{aa5fd130593a4d118c17c405649d66b0,

title = "The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review",

abstract = "To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.",

keywords = "Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bayes Theorem, Diabetic Retinopathy, Humans, Macular Edema, Markov Chains, Monte Carlo Method, Treatment Outcome, Visual Acuity",

author = "Ford, {John A.} and Andrew Elders and Deepson Shyangdan and Pamela Royle and Norman Waugh",

year = "2012",

doi = "10.1136/bmj.e5182",

language = "English",

volume = "345",

journal = "BMJ-British Medical Journal",

issn = "1759-2151",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

AU - Ford, John A.

AU - Elders, Andrew

AU - Shyangdan, Deepson

AU - Royle, Pamela

AU - Waugh, Norman

PY - 2012

Y1 - 2012

N2 - To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

AB - To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

KW - Angiogenesis Inhibitors

KW - Antibodies, Monoclonal, Humanized

KW - Bayes Theorem

KW - Diabetic Retinopathy

KW - Humans

KW - Macular Edema

KW - Markov Chains

KW - Monte Carlo Method

KW - Treatment Outcome

KW - Visual Acuity

U2 - 10.1136/bmj.e5182

DO - 10.1136/bmj.e5182

M3 - Article

C2 - 22890029

VL - 345

JO - BMJ-British Medical Journal

JF - BMJ-British Medical Journal

SN - 1759-2151

M1 - e5182

ER -